Dasatinib for the Treatment of Moderate and Severe COVID-19

Clinical trial NCT04830735 · WITHDRAWN

Trial details

NCT number: NCT04830735
Sponsor: University of Southern California
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Symptomatic COVID-19 Infection Laboratory-Confirmed

Start date: 2022-08-05
Primary completion: 2023-12-15
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.